Back to Results
First PageMeta Content
Pharmaceuticals policy / Morphinans / Clinical pharmacology / Combination drugs / Formulary / Medicare Part D / Codeine / Oxycodone / Medical prescription / Pharmacology / Medicine / Pharmaceutical sciences


2014 Prescription Drug Formulary This formulary was updated on[removed]For more recent information or other questions, please contact Essence Healthcare, Inc. Customer Service at[removed]or, for TTY users, 711
Add to Reading List

Document Date: 2014-09-08 16:54:58


Open Document

File Size: 1,92 MB

Share Result on Facebook

Company

HP / Essence Healthcare Inc. / /

Event

FDA Phase / /

Facility

Pharmacy Directory / /

IndustryTerm

pharmacy network / co-payments/co-insurance / /

Organization

Food and Drug Administration / Medicare / /

Person

MO MO QL / MO MO MO / MO MO MO MO / MO MO MO QL / MO QL / /

/

Position

Governor / physician / /

Product

lortab / AVINZA / acetaminophen / sumatriptan / fentanyl citrate / OPANA ER / morphine sulfate / COUMADIN / ibuprofen / REPREXAIN / PERCODAN / tramadol hydrochloride / ROXICET / DILAUDID-HP / sumatriptan succinate / vicodin es / ULTRAM ER / TYLENOL / SYNALGOS-DC / nalbuphine / fentanyl / butorphanol tartrate / vicodin hp / OXYCONTIN / vicodin / KADIAN / levorphanol tartrate / Customer Service / FENTORA / DILAUDID / Analgesics Opioid Analgesics / Y0027 / /

URL

www.medicare.gov / www.essencehealthcare.com / /

SocialTag